# APREMILAST
> **ANDA211674** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2023-10-16
## Drug
- **FDA Application Number:** ANDA211674
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APREMILAST
- **Generic name:** Apremilast
- **Active ingredients:** APREMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLENMARK PHARMS LTD
- **First approval:** 2023-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211674)
---
*AI Analytics · CC0 1.0*